The novel modifications of substrate-containing sodium dodecyl sulfate-polyacrylamide gel electrophoresis that can be used for the detection of proteases and its activators are reported. The protease/activator samples were separated on a protein substrate-SDS-polyacrylamide gel. To detect plasminogen activators fibrinogen and Glu-plasminogen were incorporated into the SDS-PAG followed by 1 h incubation at 37?C in thrombin solution (1 NIH/ml). After electrophoresis the gel was stained according to the standard protocol. To detect fibrin-unspecific plasminogen activators from snake venom incubation in thrombin solution was substituted for 12 h incubation in 50 mM Tris-HCl (pH 7.4). To detect fibrinogen-degrading enzymes fibrinogen-containing gel was used. Activity of protease/activator was visualized in the gel as clear bands against the dark background. These new techniques offer several advantages including determination of the quantity and activity of t-PA and urokinase, however cannot be recommended for precise quantification of activators; the total procedure is quite quick and simple; method is convenient tool for detection of novel protein-protein interactions in haemostasis system; the sensitivity of the method is ≤0.01 IU per track.
Westermeeier, R. and Naven, T. (2002) Proteomics in practice: A laboratory manual of proteome analysis, Wiley-VCH Verlag GmbH.
Erickson, L., Lawrence, D. and Loskutoff, D. (1984) Reverse fibrin autography: A method to detect and partially characterize protease inhibitors after sodium dodecyl sulfate—polyacrylamide gel electrophoresis. Analytical Biochemistry, 137, 454-463. doi:10.1016/0003-2697(84)90113-1
Brunner, G. and Schirrmacher, V. (1988) Fibrin autography of plasminogen activator by electrophoretic transfer into fibrin agar gels. Analytical Biochemistry, 168, 411-416. doi:10.1016/0003-2697(88)90337-5
Hanspal, J., Bushell, G. and Ghosh, P. (1983) Detection of protease inhibitors using substrate-containing sodium dodecyl sulfate-polyacrylamide gel electrophoresis. Analytical Biochemistry, 132, 288-293. doi:10.1016/0003-2697(83)90010-6
Zhao, Z. and Russell, P. (2003) Trypsin activity assay in substrate-specific one- and two-dimensional gels: A powerful method to separate and characterize novel proteases in active form in biological samples. Electrophoresis, 24, 3284-3288. doi:10.1002/elps.200305531
Le, Q., Ohashi, A., Hirose, S. and Katunuma, N. (2005) Reverse zymography using fluorogenic substrates for protease inhibitor detection. Electrophoresis, 26, 1038- 1045. doi:10.1002/elps.200306142
Wilkesman, J. and Schroder, H. (2007) Analysis of serine proteases from marine sponges by 2-D zymography. Electrophoresis, 28, 429-436. doi:10.1002/elps.200600332
Le, Q. and Katunuma, N. (2004) Detection of protease inhibitors by a reverse zymography method, performed in a tris(hydroxymethyl)aminomethane-Tricine buffer system. Analytical Biochemistry, 324, 237-240. doi:10.1016/j.ab.2003.09.033
Martinez, M., Newbold, C., Wallace, R. and Movano, F. (2002) Effects of high-molecular-mass substrates on protein migration during sodium dodecyl sulfatepolyacrylamide gel electrophoresis. Electrophoresis, 23, 1-7.
Vazquez, D. and Peyronel, A.C. (1995) A simple and rapid technique for postelectrophoretic detection of proteases using azocasein. Electrophoresis, 16, 1894-1897.
Fareed, J., Hoppensteadt, D. and Leya, F. (1998) Useful laboratory tests for studying thrombogenesis in acute cardiac syndromes. Clinical Chemistry, 44, 1845-1853.
Zawilska, K. (1995) Progress in the detection of intravascular activation of fibrinolysis. Acta haematologica polonica, 26, 33-38.
Bu, C., Zhang, C. and Li, Z. (2007) Autoantibodies to plasminogen and tissue plasminogen activator in women with recurrent pregnancy loss. Clinical & Experimental Immunology, 149, 31-39. doi:10.1111/j.1365-2249.2007.03382.x
Hoylaerts, M., Rijken, D., Lijnen, H. and Collen, D. (1982) Kinetics of the activation of plasminogen by human tissue plasminogen activator. Role of fibrin. Journal of Biological Chemistry, 257, 2912-2919.
Protein Electrophoresis. (1999) Technical manual, Amersham Biosciences Inc.
Heussen, C. and Dowdle, E. (1980) Electrophoretic analysis of plasminogen activators in polyacrylamide gels containing sodium dodecyl sulfate and copolymerized substrates. Analytical Biochemistry, 102, 196-202. doi:10.1016/0003-2697(80)90338-3
Harlow, E. and Lane, D. (1988) Antibodies. Cold Spring Harbor Laboratory, New York.
Chibber, B., Deutsch, D. and Mertz, E. (1974) Affinity chromatography of plasminogen. Methods in Enzymology, 34, 424-432.
Wiman, B. and Wallen, P. (1973) Activation of human plasminogen by an insoluble derivative of urokinase. Structural changes of plasminogen in the course of activation to plasmin and demonstration of a possible intermediate compound. European Journal of Biochemistry, 36, 25-31. doi:10.1111/j.1432-1033.1973.tb02880.x
March, S., Parikh, I. and Cuatrecasas, P. (1974) A simplified method for cyanogen bromide activation of agarose for affinity chromatography. Analytical Biochemistry, 60, 149-152. doi:10.1016/0003-2697(74)90139-0
Krasnobryzha, E., Savchuk, O. and Volkov, G. (2004) Study of streptokinase influence on the haemostasis system parameters in model systems in vivo. Ukrainian Biochemical Journal, 76, 56-61.
Savchuk, O., Levkin, M., Karbovskyy, V., Gornitskaya, O., Volkov, G. and Tseren, B. (2006) Plasminogen activatof from Agkistrodon halys halys venom. Ukrainian Biochemical Journal, 78, 32-37.
Platonova, T., Gornitskaya, O., Metelitsina, I. and Savchuk, O. (2001) Components of blood clotting system and fibrinolytic system in subretinal fluid at regmatogenic retina exfoliation. Medichna Chimia, 3, 5-8.
Petik, A., Platonova, T. and Savchuk, O. (2001) Indexes of haemostasis system during Lewis carcinoma growth. Experimental Oncology, 23, 73-75.
Zhukova, A., Krasnobrysha, I. Savchuk, O. and Volkov, G. (2009) The investigation of protein-protein interactions in haemostasis system using enzyme electrophoresis method. XXII Congress of the International Society of Thrombosis and Haemostasis. Journal of Thrombosis and Haemostasis, 7, Boston, USA, 367.
Bruhn, H., Conard, J., Mannucci, M., Monteagudo, J., Pelzer, H., Reverter, J., Samama, M., Tripodi, A. and Wagner, C. (1992) Multicentric evaluation of a new assay for prothrombin fragment F1 + 2 determination. Thromb Haemost, 68, 413-417.
Ferlito, S., Gallina, M., Mangiameli, S. and Chiaranda, G. (1995) Thrombotic markers during myocardial infarctionPanminerva. Panminerva Medica, 37, 133-136.
Granger, C., Becker, R., Tracy, R., Califf, R., Topol, E., Pieper, K., Ross, A., Roth, S., Lambrew, C. and Bovill, E. (1998) Thrombin generation, inhibition and clinical outcomes in patients with acute myocardial infarction treated with thrombolytic therapy and heparin: Results from the GUSTO-I Trial. GUSTO-I Hemostasis Substudy Group. Global Utilization of Streptokinase and TPA for Occluded Coronary Arteries. Journal of the American College of Cardiology, 31, 497-505. doi:10.1016/S0735-1097(97)00539-1
Johns, J., Gold, H., Leinbach, R., Yasuda, T., Gimple, L., Werner, W., Finkelstein, D., Newell, J., Ziskind, A. and Collen, D. (1988) Prevention of coronary artery reocclusion and reduction in late coronary artery stenosis after thrombolytic therapy in patients with acute myocardial infarction. A randomized study of maintenance infusion of recombinant human tissue-type plasminogen activator. Circulation, 78, 546-556.
Nilsen, D., Goransson, L., Larsen, A., Hetland, O. and Kierulf, P. (1997) Systemic thrombin generation and activity resistant to low molecular weight heparin administered prior to streptokinase in patients with acute myocardial infarction. Tromb Haemost, 77, 57-61.
Chandler, W. and Stratton, J. (1994) Laboratory evaluation of fibrinolysis in patients with a history of myocardial infarction. American Journal of Clinical Pathology, 102, 248-252.
Genser, N., Lechleitner, P., Maier, J., Dienstl, F., Artner-Dworzak, E., Puschendorf, B. and Mair, J. (1998) Rebound increase of plasminogen activator inhibitor type I after cessation of thrombolytic treatment for acute myocardial infarction is independent of type of plasminogen activator used. Clinical Chemistry, 44, 209-214.
Yamada, S., Yamada, R., Ishii, A., Ashikawa, K., Kawamitsu, H. and Fujita, K. (1996) Evaluation of tissue plasminogen activator and plasminogen activator inhibitor-I levels in acute myocardial infarction. Journal of Cardiology, 27, 171-178.
Markland, F. (1998) Snake venoms and the hemostatic system. Toxicon, 36, 1749-1800. doi:10.1016/S0041-0101(98)00126-3
Immonen, I., Konttinen, Y., Sorsa, T., Tommila, P. and Sirén, V. (1996) Proteinases in subretinal fluid. Graefes Archive for Clinical and Experimental Ophthalmology, 234, 105-109. doi:10.1007/BF00695249
O’Reilly, M. (1997) Angiostatin: An endogenous inhibitor of angiogenesis and of tumor growth. EXS, 79, 273-294.
Geiger, J. and Cnudde, S. (2004) What the structure of angiostatin may tell us about its mechanism of action. Thromb Haemost, 2, 23-34. doi:10.1111/j.1538-7836.2004.00544.x
Chen, Y., Wu, H., Li, C., Huang, Y., Chiang, C., Wu, M. and Wu, L. (2006) Anti-angiogenesis mediated by angiostatin K1-3, K1-4 and K1-4.5. Involvement of p53, FasL, AKT and mRNA deregulation. Thromb Haemost, 95, 668-677.
Wang, H., Doll, J., Jiang, K., Cundiff, D., Czarnecki, J., Wilson, M., Ridge, K. and Soff, G. (2006) Differential binding of plasminogen, plasmin, and angiostatin 4.5 to cell surface beta-actin: Implications for cancer-mediated angiogenesis. Cancer Research, 66, 7211-7215. doi:10.1158/0008-5472.CAN-05-4331
Kastrikina, T., Taran, L. and Kudinov, S. (1986) Kinetic characteristics of fibrinogen and fibrin hydrolysis by plasmin 1 and 2 and miniplasmin. Thromb Research, 41, 681-688. doi:10.1016/0049-3848(86)90365-8
Kolev, K., Komorowicz, E., Owen, W. and Machovich, R. (1996) Quantitative comparison of fibrin degradation with plasmin, miniplasmin, neurophil leukocyte elastase and cathepsin G. Thromb Haemost, 75, 140-146.
Kolev, K., Léránt, I., Tenekejiev, K. and Machovich, R. (1994) Regulation of fibrinolytic activity of neutrophil leukocyte elastase, plasmin, and miniplasmin by plasma protease inhibitors. Journal of Biological Chemistry, 269, 17030-17034.
Ponting, C., Marshall, J. and Cederholm-Williams, S. (1992) Plasminogen: A structural review. Blood Coagulation & Fibrinolysis, 3, 605-614.